跳到主要內容區塊

水產種苗研究團隊-水產疫苗發展、評估與應用技術建立之研究

  • 日期:100-04-08
  • 計畫編號:99農科-1.1.2-水-A5
  • 年度:2010
  • 領域:農業生物技術研發領域
  • 主持人:郭錦朱

本研究旨在開發海鱺發光桿菌疫苗製劑,以不活化菌體、細菌胞外液及弗氏佐劑製備候選疫苗製劑,由其抗體反應,評估海鱺發光桿菌疫苗的最佳製備方法。結果發現,製備的候選疫苗製劑中,以不活化菌體及弗氏佐劑混合製劑的抗體力價最高,於接種後2935天,海鱺的凝集抗體力價可達416960倍,且不活化菌體的組成菌量以8.4×1091.7×1010 cells/fish最佳 (p<0.05);其安全注射量則為0.10.6 ml/fish。

研究報告摘要(英)


The aim of this study was to screen preparation method of Photobacterium damselae subsp. piscicida vaccine for cobia (Rachycentron canadum). Various candidate vaccines combined with inactivated bacteria, extracellular products and Freund’s adjuvant were involved to assay their efficiency against photobacteriosis by the antibody response. The results showed that the best candidate vaccine were found that was an admixture of inactivated bacteria of 8.4×109-1.7×1010 cells/fish (p<0.05) and Freund’s adjuvant which produced high antibody titter of 1:416-1:960 during 29-35 days post-vaccination, and their safety doses for intraperitoneally vaccinated cobia were 0.1-0.6 ml/fish.